SLP Insider Sale: Lisa LaVange Disposes of 867 Shares Under 10b5-1 Plan

Rhea-AI Filing Summary

Simulations Plus director Lisa LaVange reported the sale of 867 shares of the company's common stock on 09/02/2025. The Form 4 states the shares were sold in a single transaction at $14.10 per share and that the sale was effected automatically pursuant to a Rule 10b5-1 trading plan. Following the reported transaction, Ms. LaVange beneficially owns 9,063 shares and holds those shares in a direct ownership form. The filing indicates the reporter is a director and the Form 4 was executed by an attorney-in-fact on 09/04/2025.

Positive

• Transaction disclosed as executed under a Rule 10b5-1 plan, indicating a prearranged trade and transparency
• Full transaction details provided including date, number of shares, and sale price ($14.10)

Negative

• Insider sale of 867 shares reduces the director's holding to 9,063 shares
• No information on total outstanding shares or percentage ownership is provided in this filing, limiting assessment of materiality

Insights

Financial Analyst

TL;DR: Director sold 867 shares under a 10b5-1 plan at $14.10, leaving 9,063 shares beneficially owned.

The reported transaction is explicitly labeled as executed under a Rule 10b5-1 plan, which signals a prearranged sale rather than opportunistic trading. The sale price of $14.10 and the quantity of 867 shares are disclosed, and the remaining beneficial ownership is reported as 9,063 shares. From a shareholder perspective, this filing provides transparent disclosure of an insider disposition but contains no further financial metrics or change in control indicators.

Corporate Governance Expert

TL;DR: Disclosure shows compliance with Section 16 and use of a 10b5-1 plan; filing appears procedurally complete.

The Form 4 lists the reporting person as a director and marks the transaction as pursuant to a 10b5-1 plan, which helps establish the affirmative defense to insider trading claims. The form reports direct ownership and provides the transaction date and execution details. The signature was provided by an attorney-in-fact, which is permitted and noted on the form. No amendments or additional arrangements are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LaVange Lisa

(Last) (First) (Middle)

800 PARK OFFICES DRIVE

SUITE 401

(Street)

RESEARCH TRIANGLE PARK NC 27709

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Simulations Plus, Inc. [ SLP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		S(1)		867	D	$14.1(2)	9,063	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.

2. These shares were sold in a single transaction at $14.10.

Remarks:

	/s/ William Frederick, attorney-in-fact for Lisa LaVange	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Simulations Plus director Lisa LaVange report on Form 4 (SLP)?

The Form 4 reports a sale of 867 shares of Simulations Plus common stock on 09/02/2025 at $14.10 per share.

Was the sale by Lisa LaVange part of a 10b5-1 plan?

Yes. The filing states the sales were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.

How many Simulations Plus shares does Lisa LaVange beneficially own after the sale?

The Form 4 reports that Ms. LaVange beneficially owns 9,063 shares following the transaction.

What was the sale price reported on the Form 4 for SLP?

The shares were sold in a single transaction at a price of $14.10 per share.

Who signed the Form 4 for Lisa LaVange and when?

The Form 4 was signed by William Frederick, attorney-in-fact for Lisa LaVange on 09/04/2025.